These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7490724

  • 21. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E, Rizzi CA, Candura SM, Lucchelli A, Balestra B, Tonini M.
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [Abstract] [Full Text] [Related]

  • 22. Is the action of cisapride on the guinea-pig ileum mediated via 5-HT4 receptors?
    Meulemans AL, Schuurkes JA.
    Eur J Pharmacol; 1992 Feb 25; 212(1):51-9. PubMed ID: 1555639
    [Abstract] [Full Text] [Related]

  • 23. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
    Candura SM, Messori E, Franceschetti GP, D'Agostino G, Vicini D, Tagliani M, Tonini M.
    Br J Pharmacol; 1996 Aug 25; 118(8):1965-70. PubMed ID: 8864530
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors.
    Lamirault L, Simon H.
    Neuropharmacology; 2001 Dec 25; 41(7):844-53. PubMed ID: 11684148
    [Abstract] [Full Text] [Related]

  • 25. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP.
    Br J Pharmacol; 2004 Nov 25; 143(5):549-60. PubMed ID: 15466450
    [Abstract] [Full Text] [Related]

  • 26. Increased defaecation caused by 5-HT4 receptor activation in the mouse.
    Banner SE, Smith MI, Bywater D, Gaster LM, Sanger GJ.
    Eur J Pharmacol; 1996 Jul 18; 308(2):181-6. PubMed ID: 8840130
    [Abstract] [Full Text] [Related]

  • 27. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. Synthesis and structure-activity relationships of 9-methyl-2,3,4,9-tetrahydrothiopyrano[2,3-b]indol-4-one derivatives.
    Suzuki T, Matsuhisa A, Miyata K, Yanagisawa I, Ohta M.
    Chem Pharm Bull (Tokyo); 1997 Jan 18; 45(1):101-6. PubMed ID: 9023971
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y, Akuzawa S, Miyata K, Kamato T, Suzuki T, Ito H, Yamaguchi T.
    Pharmacol Res; 1999 May 18; 39(5):375-82. PubMed ID: 10328995
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.
    Prins NH, Van Haselen JF, Lefebvre RA, Briejer MR, Akkermans LM, Schuurkes JA.
    Br J Pharmacol; 1999 Jul 18; 127(6):1431-7. PubMed ID: 10455293
    [Abstract] [Full Text] [Related]

  • 32. Regional difference in correlation of 5-HT4 receptor distribution with cholinergic transmission in the guinea pig stomach.
    Takada K, Sakurai-Yamashita Y, Yamashita K, Kaibara M, Hamada Y, Nakane Y, Hioki K, Taniyama K.
    Eur J Pharmacol; 1999 Jun 25; 374(3):489-94. PubMed ID: 10422794
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists.
    Kakigami T, Usui T, Tsukamoto K, Kataoka T.
    Chem Pharm Bull (Tokyo); 1998 Jan 25; 46(1):42-52. PubMed ID: 9468636
    [Abstract] [Full Text] [Related]

  • 35. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ, Schuurkes JA.
    J Pharmacol Exp Ther; 1993 Jan 25; 264(1):79-88. PubMed ID: 8093733
    [Abstract] [Full Text] [Related]

  • 36. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M, Hallett DJ, Goodacre S, Moyes C, Crawforth J, Sparey TJ, Patel S, Marwood R, Patel S, Thomas S, Hitzel L, O'Connor D, Szeto N, Castro JL, Hutson PH, MacLeod AM.
    J Med Chem; 2001 May 10; 44(10):1603-14. PubMed ID: 11334570
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J, Mercè R, Díaz JL, Guitart X, Codony X, Dordal A, Romero G, Torrens A, Mas J, Andaluz B, Hernández S, Monroy X, Sánchez E, Hernández E, Pérez R, Cubí R, Sanfeliu O, Buschmann H.
    J Med Chem; 2005 Mar 24; 48(6):1781-95. PubMed ID: 15771424
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.